Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Jefferies
Jefferies analyst Akash Tewari lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $90.00 (from $113.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
